Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
life sciences
national blog main
boston
boston top stories
aldehyde
aldeyra therapeutics
allergic conjunctivitis
alnylam pharmaceuticals
amgen
andrew berens
avapritinib
blueprint medicines
cancer
cholesterol
deciphera pharmaceuticals
drugs
dry eye disease
gastrointestinal stromal tumor
gist
gleevec
imatinib
inclisiran
national top stories
new york
new york blog main
new york top stories
pcsk9 inhibitors
praluent
regeneron pharmaceuticals
regorafenib
repatha
reproxalab
ripretinib
sjogren-larsson syndrome
steve hoerter
stivarga
sunitinib
sutent
What
fda
4
×
filing
4
×
drug
closer
market
medicine
morning
new
phase
positive
type
according
aldeyra
announced
approval
blueprint
bringing
called
campaign
cancer
chasing
cholesterol
clearance
cleared
clears
company
crowdfunding
cur
data
deadly
deciphera
developing
device
disclosed
doing
doom
eye
fast
fighting
forms
Language
unset
Current search:
filing
×
fda
×
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@theverge.com
8 years ago
Cur is crowdfunding a medical device that isn't cleared by the FDA, and that's a problem